These findings suggest that some drugs used in the treatment of Behçet’s disease may have either positive or negative effects on syndecan-1, and there may be a relationship between syndecan-1 levels and cardiovascular damage in Behçet’s disease, which has a complex etiology. The gene discussed is SDC1; the disease is Behcet disease.